Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?

about

Alveolar bone in human immunodeficiency virus infection: is it changed by long-term antiretroviral therapy?

Item

http://www.wikidata.org/entity/Q39172721

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@en

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@nl

type

Item

label

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@en

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@nl

prefLabel

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@en

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@nl

P1476

Alveolar bone in human immunod ...... g-term antiretroviral therapy?

@en

P2093

Aree Kanjanaprapas

http://www.w3.org/2001/XMLSchema#string

Hutcha Sriplung

http://www.w3.org/2001/XMLSchema#string

Kanokporn Pangsomboon

http://www.w3.org/2001/XMLSchema#string

Pratanporn Arirachakaran

http://www.w3.org/2001/XMLSchema#string

Wipawee Nittayananta

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Bone resorption by osteoclasts

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.

The osteoblast: a sophisticated fibroblast under central surveillance.

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

Bone mass and mineral metabolism in HIV+ postmenopausal women.

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.

Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies.

Bone quality--the material and structural basis of bone strength and fragility.

P304

123-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IDJ.12265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27864831

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug